Home 
Acta Virologica 2016 Acta Virologica Vol.60, No.2, p.166-173, 2016
Acta Virologica 2016 Acta Virologica Vol.60, No.2, p.166-173, 2016
Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Current articles 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Acta Virologica Vol.60, No.2, p.166-173, 2016 |
||
| Title: Characterization of two anti-dengue human monoclonal antibodies prepared from PBMCs of patients with dengue illness in Thailand | ||
| Author: Z.-Y. LI, A. YAMASHITA, N. KAWASHITA, T. SASAKI, Y. PAN, K.-I. ONO, K. IKUTA, Y.-G. LI | ||
| Abstract: The global spread of the four dengue virus (DENV) serotypes (dengue-1 to -4) has made this virus a major and growing public health concern. Generally, pre-existing neutralizing antibodies derived from primary infection play a significant role in protecting against subsequent infection with the same serotype. By contrast, these pre-existing antibodies are believed to mediate a non-protective response to subsequent heterotypic DENV infections, leading to the onset of dengue illness. In this study, two monoclonal antibodies prepared by using peripheral blood mononuclear cells (PBMCs) from patients with dengue fever were characterized. Epitope mapping revealed that amino acid residues 254–278 in domain II of the viral envelope protein E were the target region of these antibodies. A database search revealed that certain sequences in this epitope region showed high conservation among the four serotypes of DENV. These two human monoclonal antibodies could neutralize DENV-2,-4 more effectively than DENV-1,-3. The amino acid sequences could not explain this difference in neutralizing activity. However, the 3D structure results showed that amino acid 274 could be the critical residue for the difference in neutralization. These results may provide basic information for the development of a dengue vaccine. |
||
| Keywords: human monoclonal antibody; epitope; dengue virus | ||
| Published online: 06-Jun-2016 | ||
| Year: 2016, Volume: 60, Issue: 2 | Page From: 166, Page To: 173 | |
| doi:10.4149/av_2016_02_166 |
||
|
|
 download file |
|